Sanjay Malkani is the Global President of Lab Solutions for LumiraDx, overseeing a team disrupting the Molecular Testing industry with rapid reagent solutions. He is also a Partner and Director of Specialty Moedical Distributor Versea, Inc. in Tampa, and Director of Omega Laboratories, Inc. with multiple US and Canadian sites. He brings 20+ years of experience in leading and growing Global diagnostic businesses.

For the decade ending Q1’18, Sanjay served as Global President of the Toxicology division of Alere, Inc (NYSE: ALR), the Global leader in toxicology products, services, and rapid diagnostics. Sanjay platformed and gre the business from ~$50MM to ~$650MM, deploying ~$1.1B into over 30 merged assets form a stand-alone division of 2,700+ global employees, driving significant value creation as measured by a leading Board advisory firm. As a named executive officer and member of the company’s executive team, he supported Alere’s $5.2 billions sale to Abbott Laboratories, Inc (NYSE: ABT) in 2017.

Sanjay holds an MBA from the Kellogg School at Northwestern University (1998) and an undergraduate degree in Industrial Engineering from Purdue University (1991).